140 related articles for article (PubMed ID: 17030702)
1. Th1 adaptive immune responses in cardiac graft arteriosclerosis: deleterious or beneficial?
Tellides G
Circulation; 2006 Oct; 114(15):1561-4. PubMed ID: 17030702
[No Abstract] [Full Text] [Related]
2. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
[TBL] [Abstract][Full Text] [Related]
3. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma axis in graft arteriosclerosis.
Tellides G; Pober JS
Circ Res; 2007 Mar; 100(5):622-32. PubMed ID: 17363708
[TBL] [Abstract][Full Text] [Related]
5. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
[TBL] [Abstract][Full Text] [Related]
6. The role of histoincompatibility in cardiac allograft vasculopathy.
Costanzo MR
J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482
[No Abstract] [Full Text] [Related]
7. Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease?
Hauptman PJ; Nakagawa T; Tanaka H; Libby P
J Heart Lung Transplant; 1995; 14(6 Pt 2):S173-80. PubMed ID: 8719481
[No Abstract] [Full Text] [Related]
8. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection?
Chen Y; Wood KJ
Transplantation; 2007 Nov; 84(9):1071-4. PubMed ID: 17998858
[TBL] [Abstract][Full Text] [Related]
10. Herpes virus infections, acute rejection, and transplant arteriosclerosis in human cardiac allografts.
Jäkel KT; Löning T
Transplant Proc; 1993 Apr; 25(2):2029-30. PubMed ID: 8385831
[No Abstract] [Full Text] [Related]
11. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs.
Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M
Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection and the development of cellular rejection.
Fyfe AI
J Heart Lung Transplant; 1994; 13(2):343. PubMed ID: 8031820
[No Abstract] [Full Text] [Related]
13. [Mechanisms of transplant vasculopathy].
Baron H; Plenz G; Deng MC
Dtsch Med Wochenschr; 2004 Oct; 129(41):2193-7. PubMed ID: 15457400
[TBL] [Abstract][Full Text] [Related]
14. Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection.
Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; Hernández-Boluda JC; Remigia MJ; Jarque I; Calabuig ML; Garcia-Noblejas A; Alberola J; Tamarit A; Gimeno C; Navarro D
Haematologica; 2008 Sep; 93(9):1434-6. PubMed ID: 18603553
[No Abstract] [Full Text] [Related]
15. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift.
Mehra MR; Ventura HO; Stapleton DD; Smart FW
J Heart Lung Transplant; 1995; 14(6 Pt 2):S207-11. PubMed ID: 8719487
[No Abstract] [Full Text] [Related]
16. Vascular cells have limited capacities to activate and differentiate T cells: implications for transplant vascular sclerosis.
Pober JS; Ma W; Biedermann B; Libby P
Transpl Immunol; 1997 Dec; 5(4):251-4. PubMed ID: 9504143
[No Abstract] [Full Text] [Related]
17. Accelerated arteriosclerosis in heart transplant recipients: an immunopathology study of 22 transplanted hearts.
Hruban RH; Beschorner WE; Baumgartner WA; Augustine SM; Reitz BA; Hutchins GM
Transplant Proc; 1991 Feb; 23(1 Pt 2):1230-2. PubMed ID: 1989197
[No Abstract] [Full Text] [Related]
18. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches.
Rabinovitch M; Molossi S; Clausell N
J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473
[No Abstract] [Full Text] [Related]
19. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
20. Cardiac allograft vasculopathy--the cellular attack.
Hutchinson IV
Z Kardiol; 2000; 89 Suppl 9():IX/16-20. PubMed ID: 11151784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
